Yan Wong

Yan Wong is a PhD-trained scientist specializing in molecular pharmacology and neuroscience, currently serving as the Associate Director at Alexion AstraZeneca Rare Disease. They possess expertise in CRISPR-Cas9 editing, gene manipulation, and microscopy live-cell imaging assays. Yan has extensive experience in both in vitro and in vivo models and has established a strong track record of publications in top-tier journals while successfully engaging in grant writing. Previously, they held positions as Principal Scientist at Boehringer Ingelheim and Investigator at Novartis Institutes for BioMedical Research, among other esteemed institutions. Yan's research contributions further include a postdoctoral fellowship at Harvard Medical School and a graduate research role at the University of Pittsburgh School of Medicine.